Document is current
Any future updates will be listed below
-
Authors
Tirgar, Aliasghar
Rezaei, Masoud
Ehsani, Mohammadhadi
Salmani, Zahra
Rastegari, Armin
Jafari, Elham
Khandani, Behjat Kalantari
Nakhaee, Nouzar
Khaksari, Mohammad
Moazed, Vahid
-
Funding
Funding for this research was provided by:
Kerman University of Medical Sciences, Iran (98000252, 98000252, 98000252, 98000252, 98000252, 98000252, 98000252, 98000252, 98000252, 98000252)
- License Information
-
More Information
Article History
Received: 26 May 2024
Accepted: 4 September 2024
First Online: 12 September 2024
Competing interests
: The probiotic supplements were graciously supplied by Zist Takhmir Pharmaceutical Company to Dr. Vahid Moazed, with a transparent affirmation that the company did not participate in the formulation of the study hypothesis, design, implementation, analysis, or interpretation thereof. The other authors declare no competing interests. The authors of this study gratefully acknowledge the financial support provided by the Kerman University of Medical Sciences.
: The research study's protocol has been officially registered in the Iranian Registry of Clinical Trials (IRCT) under the registration number IRCT 20200313046756N1 (date: 28–3-2020). The study was conducted in accordance with the Declaration of Helsinki, and informed consent was obtained from all participants before enrollment. The experimental protocols involving human participants and/or the utilization of human tissue samples received review and authorization from the Ethics Committee of Kerman University of Medical Sciences. The project underwent ethical scrutiny and was approved, adhering to the ethical standards observed by the committee. The ethical approval identifier for this study is IR.KMU.REC.1398.709.
